Squarepoint
DTIL icon

Squarepoint’s Precision BioSciences DTIL Stock Holding History

Squarepoint’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241K Buy
+43,848
New +$202K ﹤0.01% 3853
2025
Q1 		– Sell
-46,929
Closed -$179K – 4774
2024
Q4 		$179K Buy
+46,929
New +$343K ﹤0.01% 4511
2023
Q4 		– Sell
-3,385
Closed -$34.7K – 4098
2023
Q3 		$34.7K Buy
+3,385
New +$52K ﹤0.01% 3665
2022
Q2 		– Sell
-769
Closed -$71K – 2988
2022
Q1 		$71K Buy
769
+15
+2% +$2.04K ﹤0.01% 2651
2021
Q4 		$167K Buy
754
+404
+115% +$113K ﹤0.01% 2779
2021
Q3 		$121K Buy
+350
New +$119K ﹤0.01% 2628
2021
Q1 		– Sell
-2,108
Closed -$527K – 3224
2020
Q4 		$527K Buy
2,108
+528
+33% +$129K ﹤0.01% 1774
2020
Q3 		$292K Buy
+1,580
New +$314K ﹤0.01% 1814
2020
Q2 		– Sell
-632
Closed -$114K – 2292
2020
Q1 		$114K Sell
632
-2,242
-78% -$587K ﹤0.01% 1615
2019
Q4 		$1.2M Buy
2,874
+1,480
+106% +$465K 0.01% 1228
2019
Q3 		$351K Buy
+1,394
New +$454K ﹤0.01% 1809

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint's DTIL Position: Q1 2026 in Review

Squarepoint opened a new position in Precision BioSciences (DTIL) in Q1 2026: 43,848 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #3853 among its holdings. This is a return to the name: Squarepoint previously reported a position in DTIL as recently as Q4 2024.

Squarepoint first reported a position in DTIL in Q3 2019 and has held it in 11 quarters since. The position peaked at $1.2M in Q4 2019. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Squarepoint held 43,848 shares of Precision BioSciences worth $241K as of Q1 2026.
  • Precision BioSciences was a new Squarepoint position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3853 holding.
  • Squarepoint first reported a position in Precision BioSciences in Q3 2019 and has held it in 11 quarters since.
  • Squarepoint's Precision BioSciences position peaked at $1.2M in Q4 2019.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.